StemCyte

Proudly helping families as the industry leader in cord blood banking & research. Reach out to learn more: [email protected] or call 1.888.885.4088

[StemCyte @StemCyte]

We had an incredible few days connecting with clinicians, researchers, and partners at #AABB 2025.

Learn more about REGENECYTE™ and download our company profile: https://t.co/lbfh1mwxx6
Cell starting materials: [email protected]

#StemCyte #AABB #CordBlood #CellTherapy

[StemCyte @StemCyte]

We’re so grateful to connect the Women’s Care of Beverly Hills Medical Group! A wonderful chance to get together with their team and celebrate women’s health. Big thanks to @longshotcoffee for the adorable StemCyte lattes that made the day even sweeter ☕💜 #CordBlood

[StemCyte @StemCyte]

What’s the biggest myth you’ve heard about stem cells? ����👇

[StemCyte @StemCyte]

Stem cell therapy is often misunderstood. Here’s a breakdown of common myths vs. the scientific facts 🧬👇

[StemCyte @StemCyte]

MYTH 5: Stem cell therapy is a “miracle cure” or nothing.

REALITY: The truth is in between. Stem cells aren’t magic, but they are one of the most promising frontiers in modern medicine.

[StemCyte @StemCyte]

StemCyte signs a cooperation agreement with a cutting-edge US immune cell therapy company to supply drug preparation raw materials for allogeneic modified cell therapy https://t.co/KYX9ftrbAB

[StemCyte @StemCyte]

Cord blood is a cell therapy biological drug that StemCyte is investigating to repair fatigue and brain fog commonly seen in Post-COVID symptoms. The first Post-COVID Syndrome Phase II clinical trial has begun recruiting patients. https://t.co/6hkgfb0qHF

[StemCyte @StemCyte]

With FDA approval of the our Phase II IND, StemCyte aims to treat Post-COVID Syndrome by infusing umbilical cord blood that is capable of anti-inflammation and tissue repair for long-term effect. https://t.co/wc5CqYbjkP

[StemCyte @StemCyte]

Since 2013, 83% of transplant units through the CA-UCBCP have been provided by StemCyte https://t.co/n6xnRnVtfk

[StemCyte @StemCyte]

In the past 20 years, StemCyte has provided more than 2,200 cord blood units for transplantation to 1 in 20 patients worldwide who receive umbilical cord blood transplants. https://t.co/ahHlX3CUBP

[StemCyte @StemCyte]

"With acute stroke being the second and third leading cause of death and disability, respectively, worldwide, this outcome is as outstanding as it was unexpected.” Jonas Wang, StemCyte Chairman & President https://t.co/kvOt83khWI

[StemCyte @StemCyte]

StemCyte Announces Breakthrough Allogeneic Cell Therapy Technology in cover page article featured in the July 28 issue of Advanced Materials (Impact Factor: 27.4). https://t.co/grtGLhIgdq

[StemCyte @StemCyte]

StemCyte Inc. receives reaccreditation by AABB. Medical Director Lawrence Petz, MD, confirms zero nonconformances and an acknowledgement by the agency of the company's commitment to quality, whether banking publicly or privately. https://t.co/R0KDr4DdMS

[StemCyte @StemCyte]

Take a few moments and learn the truth about cord blood stem cells and how they can protect your growing family!

Cord blood stem cells can treat 80+ health conditions and diseases. Call us at [phone] or visit us online to learn more! https://t.co/hKVQzEl2E8

[StemCyte @StemCyte]

StemCyte's Sweetheart Special!
1. Exceptional pricing for Cord Blood and Tissue Preservation
2. Complimentary StemCyte CARE ($699 value)
3. StemVita Skincare Trio ($260 value)
Call [phone] or visit https://t.co/VuNtAVSLyR to take advantage of this SUPER sweet deal!

[StemCyte @StemCyte]

Cord blood banking can positively change lives! Share with those you care about!
https://t.co/cjGOMY6YZS

Call: [phone] or visit https://t.co/fCpDVlgkwx to review plans and enroll with StemCyte, the Pioneer in Regenerative Therapeutics.